Latest Listings And Ipos News

INOVIQ Limited reported a $3.96 million net loss for H1 2026, driven by increased R&D spend, while securing $10.2 million to accelerate its exosome-based cancer diagnostics and therapeutics pipeline.

5E Advanced Materials reports Q2 FY2026 results with increased mineral resources and key shipments, while navigating ongoing funding uncertainties.

Austral Gold has raised A$8.456 million through a strategic placement aimed at accelerating exploration and expanding processing capacity in its key South American assets.

Australian Bond Exchange Holdings has completed a $982,071 private placement, attracting new international and domestic investors to support its growth strategy.

Empire Resources has successfully raised nearly $2.9 million through the first tranche of its planned $5 million placement, with a second tranche pending shareholder approval in March.

Jayride Group Limited reports a narrower quarterly loss amid revenue challenges, secures $200,000 through convertible notes, and inks a new SaaS agreement with Thailand’s Drivemate to expand its mobility platform.

Klevo Rewards Ltd has responded to ASX concerns over a delayed director interest disclosure, attributing the lapse to administrative timing issues and pledging enhanced compliance measures.

Morphic Ethical Equities Fund Limited reported a half-year profit after tax of $1.26 million for December 2025, declaring a fully franked 1 cent dividend and continuing its share buy-back program.

Viva Leisure has announced a year-long on-market share buy-back program targeting up to 10% of its issued shares, aiming to capitalise on market volatility and reinforce its strong cash flow outlook.

Elementos Limited has raised $29.5 million through a strategic placement to L1 Capital, strengthening its financial position as it pushes forward with key tin projects in Spain and Tasmania.

Alma Metals has revealed a robust 2 million tonne copper resource at its Briggs Project in Central Queensland, setting the stage for a major drilling campaign and pre-feasibility study amid a tightening global copper market.

Botanix Pharmaceuticals has launched a A$45 million capital raising to support the expansion of its dermatology product Sofdra®, while negotiating to reduce active pharmaceutical ingredient costs by up to 40%. The raising includes a two-tranche placement and a security purchase plan, with options offered to investors.